top headlines
NICE has recommended cemiplimab for eligible adults with recurrent or [...]
Meteor Biotech has joined a South Korean government-backed consortium aimed [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
TRIMTECH Therapeutics has secured an additional $14 million in seed [...]
Cytomos is presenting its AuraCyt platform at BIO 2026, showcasing [...]
Neurological pathway illustration showing myelin sheath repair; MRI brain imaging; [...]
ViiV Healthcare has secured FDA Priority Review for its application [...]
The UK health watchdog NICE has recommended NHS reimbursement of [...]
InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]
